Background: Sudden cardiac death is a significant concern among patients with congenital heart disease (CHD). We assessed the risk of remote sudden cardiac death after congenital heart surgery.
Methods: Patients undergoing congenital heart surgery before 21 years of age between 1982 and 2003 in the Pediatric Cardiac Care Consortium registry were linked to National Death Index data through 2019. Sudden cardiac death was defined as death associated with a cardiac arrest or ventricular fibrillation diagnosis code. Standardised mortality ratios relative to the general population were calculated using Centers for Disease Control and Prevention data.
Results: Among 30,566 patients discharged after their initial surgery, 2,718 deaths occurred over a median period of 23 years (IQR 19-27). Of 463 (17%) sudden cardiac deaths, the median age was 1.7 years (IQR 0.5-16.5). The mean incidence was 7 per 10,000 person-years (95% CI: 0.64-0.77), ranging from 2.7 for left-to-right shunt lesions to 37 for single-ventricle physiology. Cardiac comorbidities including heart failure (13.6%) and arrhythmias (7.1%) were more frequent among sudden cardiac death patients. Standard mortality ratios for sudden cardiac death were elevated across all CHD types, ranging from 8.0 (95% CI: 6.3-9.6) for left-to-right shunts to 107.7 (95% CI: 88.9-126.5) for single-ventricle physiology.
Conclusion: Sudden cardiac death risk is higher post-congenital heart surgery compared to the general population. Even patients with mild CHD are at risk, highlighting the need for long-term follow-up for all patients. Heart failure and arrhythmia prevalence suggest potential therapeutic targets to reduce sudden cardiac death risk.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1017/S1047951125000277 | DOI Listing |
Front Cardiovasc Med
February 2025
Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Giant cell myocarditis is a rare and rapidly progressive disease with a high mortality rate. We present the case of a 21-year-old male without a medical history who presented with a giant left ventricle (9.9 cm, EF:10%) and in a severe clinical state.
View Article and Find Full Text PDFPolymers (Basel)
February 2025
Department of Industrial Engineering, University of Padua, 35131 Padua, Italy.
With the increasing number of people suffering from heart valve diseases (e.g., stenosis and/or insufficiency), the attention paid to prosthetic heart valves has grown significantly.
View Article and Find Full Text PDFAnimals (Basel)
February 2025
Department of Internal Medicine and Clinic of Diseases of Horses, Dogs and Cats, Wrocław University of Environmental and Life Sciences, Grunwaldzki Sq 47, 50-366 Wrocław, Poland.
Hypertrophic cardiomyopathy (HCM) is the most frequent type of cardiac disease in cats. Due to its high prevalence and risk of sudden and severe signs, the disease is an important topic of various research. Despite the focus on the clinical course of the disease, studies presenting the pathological and histopathological patterns are rare.
View Article and Find Full Text PDFDiagnostics (Basel)
February 2025
Department of Cardiology, National Heart and Lung Institute, Imperial College London, London SW7 2AZ, UK.
Sarcoidosis is a multisystem disorder characterized by non-caseating granulomas in various organs. While cardiac sarcoidosis (CS) is clinically rare, it has significant implications, including heart failure, ventricular arrhythmias, and sudden cardiac death. Speckle-tracking echocardiography has emerged as a promising tool for detecting subclinical myocardial dysfunction, which is cost-efficient and readily available.
View Article and Find Full Text PDFACS Appl Mater Interfaces
March 2025
Wanzhou District Center for Disease Control and Prevention, Chongqing, 404199, P. R. China.
Sports cardiology focuses on athletes' cardiovascular health, yet sudden cardiac death remains a significant concern despite preventative measures. Prolonged physical activity leads to notable cardiovascular adaptations, known as the athlete's heart, which can resemble certain pathological conditions, complicating accurate diagnoses and potentially leading to serious consequences such as unnecessary exclusion from sports or missed treatment opportunities. Wearable devices, including smartwatches and smart glasses, have become prevalent for monitoring health metrics, offering potential clinical applications for sports cardiologists.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!